Numerous studies have demonstrated a decline over time in the risk of surgery, which has been associated with an increase in the prescription of anti-TNFα drugs, suggesting a positive impact of anti-TNFα therapy on the natural history of IBD. Here, TNF is linked to inflammatory bowel disease.